Contrast-Only CTA Matched Multiphase Imaging for Acute Aortic Disease
Computed tomography angiography for suspected acute aortic pathology has long relied on an unenhanced phase before contrast injection, largely because intramural hematoma can be difficult to separate from mural thrombus, calcified plaque, or contrast-opacified lumen. This study challenges that habit in a concrete way. In a retrospective cohort of 160 patients with confirmed aneurysm, dissection, intramural hematoma, or penetrating atherosclerotic ulcer, a contrast-only protocol performed non-inferiorly to the standard multiphase examination for detecting and characterizing the major acute aortic lesions.
The practical consequence is immediate: one less acquisition translated into substantially less radiation without a measurable loss in diagnostic performance across the aortic segments evaluated.
Diagnostic Performance Stayed Within the Prespecified Non-Inferiority Margin
The analysis covered 640 predefined aortic segments, with two experienced radiologists reading the examinations independently. The investigators set a 5% non-inferiority margin and used generalized estimating equations to account for clustering across multiple aortic segments within the same patient. Every confidence interval for the contrast-only approach stayed inside that boundary.
Detection of aortic aneurysm was identical in both protocols, with 215 segments identified in each arm, representing 33.6% of the evaluated segments. No discordant aneurysm cases emerged. For aortic dissection, detection was nearly the same as well, at 15.6% with contrast-only imaging versus 15.9% with the full protocol. Neither difference reached statistical significance.
The small differences seen for intramural hematoma and penetrating atherosclerotic ulcer ran in the opposite direction, with slightly higher detection rates on the contrast-only images. Those higher rates mainly reflected false-positive interpretation rather than true superiority. In other words, the added unenhanced phase did not reveal a clinically meaningful pool of missed disease in this cohort.
Radiation Dose Fell by Roughly One-Third
Dose reduction was the clearest measurable benefit. Mean dose length product fell from 1392.4 ± 706.7 mGy·cm with the full protocol to 954.0 ± 500.9 mGy·cm with the contrast-only strategy. Mean CTDIvol dropped from 18.6 ± 9.2 mGy to 12.7 ± 6.6 mGy. Both reductions were statistically significant, and both translated into an average radiation decrease of about 32%.
For patients with aortic disease, that reduction matters because the burden is rarely confined to a single scan. Serial surveillance is common, and the cumulative dose from repeated CTA can become substantial over time. Removing the unenhanced phase trims exposure at the exact point where many patients accumulate the greatest imaging burden.
Agreement Between Readers Remained Strong
The image interpretation data support the feasibility of the shorter protocol. Interprotocol agreement was perfect for aneurysm shape and rupture status, with kappa values of 1.000. Agreement was lower for mural thrombus characterization, where the kappa value fell to 0.703, but that still reflects substantial consistency between readers rather than instability of the imaging method.
The more difficult distinctions clustered where CT always struggles: differentiating thrombus, wall thickening, mural calcification, and subtle wall abnormalities. Even there, the full multiphase study did not produce a decisive diagnostic advantage. Modern multidetector CT appears capable of showing the key morphological clues directly on contrast-enhanced images in many patients, especially when experienced readers examine the aorta segment by segment.
Why the Unenhanced Phase May Be Less Essential Than Tradition Suggests
The unenhanced phase was designed to provide a baseline against which subtle hyperdensity could be compared, particularly for intramural hematoma. That logic still has merit in selected cases, especially when the wall is heavily calcified or the appearance is ambiguous. Yet the pathophysiology of acute aortic injury also creates recognizable structural changes beyond simple attenuation shifts. Wall thickening, intimal displacement, contour deformity, and ulcer-like outpouching can be visible after contrast administration when spatial resolution is sufficient.
This study suggests that the diagnostic value of the unenhanced phase may be most important in edge cases rather than as a universal requirement. In a patient with repeated aortic imaging, the tradeoff may favor contrast-only acquisition if the clinical question is focused, the scanner quality is high, and image interpretation is performed by readers familiar with acute aortic syndromes.
The result is not an argument to abandon the unenhanced phase everywhere. It is evidence that its routine inclusion is not always necessary to preserve diagnostic performance.
Where the Protocol Could Fit Into Practice
These findings point toward a narrower, more selective use of unenhanced imaging in acute aortic workups. Patients undergoing serial surveillance appear to be the clearest beneficiaries, because each scan contributes to lifetime radiation burden. Institutions with high-end scanners and experienced thoracic radiology teams may be able to adopt contrast-only CTA in carefully chosen scenarios without sacrificing detection of aneurysm, dissection, IMH, or PAU.
The data also support a practical workflow question: if the contrast-enhanced images already establish the diagnosis and anatomy with adequate confidence, the unenhanced phase may add radiation without changing management. For emergency departments and vascular teams, that could shorten study time while preserving the same clinically actionable information.
Limits of the Evidence Still Shape the Decision
This was a retrospective study from a single center, and 160 patients is a modest sample for a question that spans several acute aortic entities. The cohort also included only cases with confirmed pathology and both unenhanced and contrast-enhanced phases available, so the findings do not automatically extend to all-comers with chest or back pain. Reader expertise was high, and the results may not transfer unchanged to settings with less specialized interpretation.
The central question is therefore not whether unenhanced CT has become obsolete. It is whether every patient with suspected or confirmed acute aortic pathology needs it. In this cohort, the answer was no: a contrast-only protocol maintained non-inferior detection and characterization while reducing radiation by about one-third. The residual uncertainty lies in the difficult borderline cases, where a heavily calcified aorta, equivocal wall thickening, or a subtle ulcer-like lesion may still justify the extra phase.